Sanna-Maria Käkönen
- Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models (2024)
- International Journal of Molecular Sciences
- Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model (2023)
- International Journal of Molecular Sciences
- Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model (2023)
- Cancers
- Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model (2021)
- International Journal of Molecular Sciences
- The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis (2019)
- International Journal of Molecular Sciences
- Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models (2017)
- Clinical Cancer Research
- Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis (2013)
- JNCI: Journal of the National Cancer Institute
- The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivo (2011)
- Osteoporosis International